Our data confirm recent manuscripts demonstrating that ASXL1, U2AF1 and STAG2 (encoded on the X-chromosome) are significantly more frequently mutated in male AML and MDS patients compared to female AML patients [38, 42–44]. This evidence concerns the gene U2AF1 and myelodysplastic syndrome.